The Molecular Core will provide centralized, high quality, cost-effective services to each project. These services include preparation and characterization of recombinant S100beta and mutant S100 proteins, maintenance of rat C6 glioma cells and of cell lines containing an S100beta antisense gene, synthesis of oligodeoxynucleotides, and performance of radioimmunoassays for S100beta. A senior technician will handle the needs of the members of this program project and will participate in the maintenance of resources used by the program participants. The principal investigators of each subproject will consult in advance with the core scientific director who will assist the senior technician in the planning and execution of the analyses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG010208-01
Application #
3790535
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Mrak, Robert E; Griffin, W Sue T (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26:349-54
Sheng, J G; Mrak, R E; Jones, R A et al. (2001) Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice. Neurobiol Aging 22:895-902
Nicoll, J A; Mrak, R E; Graham, D I et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-8
Russo, G L; van den Bos , C; Sutton, A et al. (2000) Phosphorylation of Cdc28 and regulation of cell size by the protein kinase CKII in Saccharomyces cerevisiae. Biochem J 351:143-50
Sheng, J G; Zhu, S G; Jones, R A et al. (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 163:388-91
Griffin, W S; Nicoll, J A; Grimaldi, L M et al. (2000) The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp Gerontol 35:481-7
Zhu, S G; Sheng, J G; Jones, R A et al. (1999) Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. J Neuropathol Exp Neurol 58:582-7
Karson, C N; Mrak, R E; Schluterman, K O et al. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4:39-45
Nishi, M; Azmitia, E C (1999) Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture. Synapse 31:186-95
Royston, M C; McKenzie, J E; Gentleman, S M et al. (1999) Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathol Appl Neurobiol 25:387-93

Showing the most recent 10 out of 59 publications